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Abstract
Background The BRadykinesia Akinesia INcordination (BRAIN) test is an online keyboard-tapping test previously validated 
as a sensitive tool for detecting signs of Parkinson’s disease.
Objectives To determine whether the BRAIN test can measure disability in MS and identify the presence of pyramidal or 
cerebellar dysfunction.
Methods Kinesia scores (KS, number of key taps in 30 s), akinesia times (AT, mean dwell time on each key) and incoor-
dination scores (IS, variance of travelling time between keys) were calculated in 39 MS patients. These were correlated 
against the Expanded Disability Status Scale (EDSS) scores, pyramidal and cerebellar functional system scores and 9-hole 
peg test scores.
Results EDSS correlated with KS (r = − 0.594, p < 0.001), AT (r = 0.464, p = 0.003) and IS (r = 0.423, p = 0.007). 9-HPT 
scores strongly correlated with KS (r = 0.926, p < 0.001). Pyramidal scores correlated with KS (r = − 0.517, p < 0.001). 
Cerebellar scores correlated with KS (r = − 0.665, p < 0.001), AT (r = 0.567, p < 0.001) and IS (r = 0.546, p = 0.007). 
Receiver operating characteristic curves demonstrate that KS can distinguish between the presence or absence of pyramidal 
and cerebellar dysfunction with area under curve 0.840 (p < 0.001) and 0.829 (p < 0.001), respectively.
Conclusions The BRAIN test can remotely measure disability in MS. Specific scores differ according to the presence and 
severity of pyramidal or extrapyramidal dysfunction. It demonstrates huge potential in monitoring disease progression in 
clinical trials.
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Introduction
A variety of outcome measures are available to assess upper 
limb function in multiple sclerosis (MS) [1]. The 9-hole peg 
test and handgrip strength are most frequently used in clini-
cal trials and several technology-supported assessment tools 
such as the MS performance test (MPST) and virtual peg 
insertion test (VPIT) are now available [2–5]. All of these 
measures require direct administration by a clinician [1]. 
Remote monitoring of neurological disease activity has the 
potential to provide quantitative outcome measures with 
reduction of additional costs or inconvenience to patients 
[6]. Consumer-friendly accelerometers, such as FitBit, pro-
vide a promising means to remotely monitor ambulation in 
multiple sclerosis, however, there is an absence of tools for 
remote monitoring of upper limb function in MS [7].
The BRadykinesia Akinesia INcordination (BRAIN) test 
is a computer keyboard-tapping test that was developed to 
Electronic supplementary material The online version of this 
article (https://doi.org/10.1007/s00415-017-8690-x) contains 
supplementary material, which is available to authorized users.
 * Alastair J. Noyce 
 a.noyce@qmul.ac.uk
1 Department of Neurology, St. George’s Hospital, London, 
UK
2 Reta Lila Weston Institute of Neurological Studies, UCL 
Institute of Neurology, London, UK
3 Department of Neurophysiology, Kings College Hospital, 
London, UK
4 Blizard Institute, Barts and the London School of Medicine 
and Dentistry, Queen Mary University of London, London, 
UK
5 Preventive Neurology Unit, Wolfson Institute of Preventive 
Medicine, Barts and the London School of Medicine 
and Dentistry, Queen Mary University of London, 
Charterhouse Square, London, UK
 Journal of Neurology
1 3
assess upper limb function in neurological disease. It has 
been validated as a sensitive tool for detecting signs of Par-
kinson’s disease and can be completed in the outpatient 
department, at home and in clinical trials using online soft-
ware [8, 9].
The test involves alternately tapping keys at the opposite 
end of a keyboard using one finger. Subjects perform this as 
fast and accurately as possible during a 30 s period and this 
is then repeated with the other hand to derive several scores. 
The Kinesia Score (KS) measures the number of taps in 
30 s, the akinesia time (AT) measures the mean dwell time 
on each key in milliseconds and the incoordination score 
(IS) measures the variance of the time interval between key-
strokes in milliseconds.
In Parkinson’s disease, KS has been shown to be signifi-
cantly lower than controls and is correlated to the severity 
of motor dysfunction, as measured by the UPDRS motor 
score (Spearman’s r = − 0.53, p < 0.001) [8]. In the same 
study, AT and IS were higher than in controls and weakly 
correlated with the degree of motor dysfunction (r = 0.27, 
p = 0.03 and r = 0.28, p = 0.03 respectively). A study using 
an earlier version of the BRAIN test in 12 patients with cere-
bellar dysfunction from a range of aetiologies found that KS 
was correlated to the score on the (unvalidated) Cerebellar 
Disease Rating Scale (r = − 0.38, p = 0.03) [10]. AT and IS 
did not correlate significantly with the degree of cerebellar 
dysfunction, but the study was limited by a small sample size 
(r = − 0.55, p = 0.06 and r = 0.30, p = 0.30, respectively).
Preliminary (unpublished) data from our group derived 
from a service development study using fampradine in MS 
patients showed that KS correlated strongly with EDSS 
(r = − 0.59, p < 0.001). The BRAIN test had not previ-
ously been studied in MS patients. In the present study, we 
aimed to confirm whether the BRAIN test could be used to 
measure disability in MS and to further characterise how 
KS, AT and IS vary in patients with pyramidal and cerebel-
lar dysfunction.
Methods
Patients with multiple sclerosis were recruited from the 
Royal London Hospital multiple sclerosis clinic. Demo-
graphic data for each subject was ascertained by interview 
and review of the medical records. This included gender, 
age, self-reported handed dominance and disease duration. 
Participants were then examined to determine the Expanded 
Disability Status Scale (EDSS) score by a trained clinician 
[11]. In determining this score, the eight functional sys-
tem (FS) scores (pyramidal, cerebellar, brainstem, sensory, 
bowel and bladder, visual, cerebral and other) were recorded. 
The FS scores for pyramidal and cerebellar functions are 
shown in supplementary materials.
Participants undertook the BRAIN test following the 
EDSS assessment. They were seated at a desktop computer 
with a keyboard and followed on-screen test instructions 
from the BRAIN test website. This included being asked to 
alternately tap the ‘s’ and ‘;’ on the keyboard as fast and as 
accurately as possible during a 30 s period. They performed 
the test once using each hand and received no assistance 
during the test. Raw data from the BRAIN test website was 
used to determine the KS, AT and IS for each hand. The 
mean KS, mean AT and mean IS for each subject was then 
calculated. Subjects were also asked to perform the 9-hole 
peg test (9HPT). They were given standardised instructions 
and the scores were calculated, as previously described [1]. 
The 9HPT scores are, therefore, given as a reciprocal of the 
mean number of seconds to complete each trial.
Descriptive statistics for these variables were calcu-
lated. For continuous variables, means were reported if the 
data were normally distributed (assessed using the Shap-
iro–Wilks test) and medians were reported if not normally 
distributed. Associations between BRAIN test, EDSS, FS 
and 9HPT scores were estimated using Spearman’s rank cor-
relation coefficient for non-normally distributed data. These 
correlation coefficients were compared using Steiger’s Z test 
with Fisher’s r-to-z transformation. Linear regression analy-
sis was used to determine the relationship between BRAIN 
tests and EDSS scores. The t test and Mann–Whitney test 
were used to compare BRAIN test scores in those patients 
with or without pyramidal or cerebellar dysfunction and 
receiver operating characteristic (ROC) curves were used 
to compare the ability of BRAIN test scores to distinguish 
patients with or without any pyramidal or cerebellar dys-
function. The pre-determined significance level for all cal-
culations was p = 0.01. All analyses were performed using 
GraphPad Prism version 6 for Mac.
The study was approved by the Queen Square Research 
Ethics Committee (09/H0716/48) and has, therefore, been 
performed in accordance with the ethical standards laid 
down in the 1964 Declaration of Helsinki and its later 
amendments. All participants provided written informed 
consent prior to inclusion in the study.
Results
Assessments were performed on 39 patients with MS; three 
participants declined to undertake the 9-HPT and a further 
three did not complete the task within a minute and were 
assigned a value of 60 s. The mean age was 43.2 years (range 
23–70), 74.4% of participants were female and 89.7% were 
right-handed.
The median disease duration was 4 years and the median 
EDSS score was 3 (range 0–6.5). The median pyramidal 
FS score was 2 (range 0–3) and median cerebellar FS score 
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was 1 (range 0–4). The mean KS was 55.6 taps (range 
21.5–87.5), the median AT was 96.5 ms (range 50.0–210.0) 
and the median IS was 10,780 ms2 (range 864–266,237). 
The median 9-HPT score was 0.047 s−1 (range 0.024–0.065).
The EDSS correlated with KS, AT and IS. The cor-
relation coefficients for KS (r = − 0.594, p < 0.001), AT 
(r = 0.464, p = 0.003) and IS (r = 0.423, p = 0.007) scores 
with EDSS were not significantly different from each other 
(z = 1.23, p = 0.211). The distribution of KS according to 
EDSS is shown in Fig. 1. Data points marked with a cross 
indicate those patients with a paraparesis in the absence of 
upper limb pyramidal weakness. An increase in the EDSS of 
1 point was associated with 4.24 fewer taps over 30 s (95% 
CI 2.19–6.29).
The 9-HPT scores strongly correlated with KS (r = 0.926, 
p < 0.001). As expected, the 9-HPT scores correlated with 
EDSS (r = − 0.640, p < 0.001). There was no significant 
difference between the correlation coefficients for 9-HPT 
and KS with EDSS (z = − 0.439, p = 0.660).
Pyramidal dysfunction was associated with abnormal KS. 
The mean KS was lower in those patients with any pyrami-
dal dysfunction compared to those without (49.6 vs 67.5 
taps, p < 0.001) and KS correlated to the pyramidal score 
(r = − 0.517, p < 0.001). AT and IS were not significantly 
different in patients with pyramidal dysfunction and did not 
correlate with pyramidal score, as shown in Table 1. The 
distribution of these KS, AT and IS for varying degrees of 
pyramidal function is shown in Fig. 2.
Cerebellar dysfunction was associated with abnormal KS, 
AT and IS. The mean KS was lower in those patients with 
cerebellar dysfunction compared to those without (46.8 vs 
64.9 taps, p < 0.001) and KS correlated to the cerebellar 
score (r = − 0.665, p < 0.001). The median AT was higher 
in those patients with any cerebellar dysfunction compared 
to those without (112.0 vs 80.5 ms, p < 0.006) and AT 
correlated to the cerebellar score (r = 0.567, p < 0.001). 
The median IS was higher in those patients with any cer-
ebellar dysfunction compared to those without (4317 vs 
13,115 ms2, p < 0.006) and IS correlated to the cerebellar 
score (r = 0.546, p = 0.007). The Spearman’s correlation 
coefficients and p values for KS, AT and IS with pyrami-
dal and cerebellar scores are shown in Table 1. Comparison 
between BRAIN test scores in patients with and without 
pyramidal or cerebellar dysfunction are summarized in the 
supplementary material. The distribution of KS, AT and IS 
for varying degrees of cerebellar function is shown in Fig. 2.
The BRAIN test distinguished between the presence 
or absence of pyramidal and cerebellar dysfunction. ROC 
curve analysis shows that KS can distinguish between the 
presence or absence of pyramidal dysfunction with an area 
under curve (AUC) of 0.840 (p < 0.001) and cerebellar 
dysfunction with an AUC of 0.829 (p < 0.001). AT and 
IS can distinguish between the presence or absence of cer-
ebellar dysfunction with an area under curve (AUC) of 
0.723 (p = 0.007) and 0.745 (p = 0.009), respectively, and 
as shown in Table 2. Most of the patients with cerebellar 
dysfunction also had significant pyramidal dysfunction (19 
of 21 patients). The two patients with scores of ≥ 1 in the 
cerebellar domain and normal pyramidal scores had an aver-
age KS 55, AT 111.5 and IS 13,850, suggesting that AT and 
IS may be more specific for cerebellar dysfunction. Con-
versely, patients with scores of ≥ 1 in the pyramidal domain 
and normal cerebellar scores (8 of 27 patients) had an aver-
age KS 58, AT 89.9 and IS 8430. Patients with deficits in 
both domains had the most abnormal scores with average KS 
45, AT 116 and IS 45,555, respectively.
Discussion
BRAIN test scores have previously been shown to differ 
between patients with Parkinson’s disease and controls and 
to correlate with Parkinson’s disease severity, as measured 
by the motor UPDRS [8, 9]. In the present study, we apply 
this clinical tool to patients with MS for the first time. We 
demonstrate that it can be used to remotely measure disease 
Fig. 1  The distribution of KS scores according to EDSS. Data points 
marked with a cross indicate participants who had a paraparesis with-
out upper limb pyramidal weakness
Table 1  Spearman’s correlation coefficients and p values for KS, AT 
and IS with pyramidal and cerebellar scores
Pyramidal score Cerebellar score
r p value r p value
KS − 0.517 < 0.001 − 0.665 < 0.001
AT 0.279 0.085 0.567 < 0.001
IS 0.187 0.255 0.546 0.007
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severity in multiple sclerosis and that specific scores differ 
according to the presence and severity of pyramidal or cer-
ebellar dysfunction.
KS, AT and IS were highly correlated with EDSS scores 
in MS patients. KS appeared to be similar to the 9-HPT 
in measuring disability in MS and demonstrated particu-
larly strong correlation with 9-HPT scores. Given that 
the BRAIN test can be administered online, this raises 
the possibility of using it in clinical trials for assessing 
disability in patients from their own home. In a previ-
ous study where controls were asked to repeat the test 
five times there was only a minimal learning effect with 
KS improving by 1.2 taps and this was not seen with AT 
and IS [8]. This highlights the potential for serial remote 
monitoring of disability in MS during trials, minimizing 
repeated time-consuming and costly hospital visits.
Fig. 2  Each graph depicts the distribution of KS, AT or IS scores for each pyramidal or cerebellar score. The error bars show the median and 
interquartile ranges
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Analysis of BRAIN test scores in MS patients with or 
without pyramidal and cerebellar dysfunction, in conjunc-
tion with the correlations of BRAIN test scores to FS scores, 
demonstrated important differences between specific BRAIN 
test scores. Pyramidal dysfunction is associated with abnor-
mal KS alone and the severity of pyramidal dysfunction 
correlates with KS. In contrast, cerebellar dysfunction was 
associated with abnormal KS, AT and IS and the severity of 
cerebellar dysfunction correlates with each of these scores. 
The caveat to these observations is that a large proportion of 
participants had both pyramidal and cerebellar dysfunction. 
In the aforementioned study, parkinsonism was associated 
with abnormal KS, AT and IS and the severity of parkin-
sonism (as measured by UPDRS) was correlated with KS 
(r = − 0.53, p < 0.001) and to a lesser degree AT (r = 0.27, 
p = 0.03) and IS (r = 0.28 and p = 0.03) [8].
KS, therefore, appears to be a non-specific marker of 
upper limb neurological impairment; reduced in parkinson-
ism, pyramidal and cerebellar dysfunction. This may be 
because it counts key taps over a given time period and in 
essence aggregates multiple facets of a complex motor task 
into a single and simple end point. By contrast, AT and IS 
measure subtle variations in a specific aspect of a repeti-
tive movement. Use of the three scores in parallel may help 
to distinguish extrapyramidal from pyramidal dysfunction. 
Overall, these findings give new insights into the versatility 
of the BRAIN test. This quantitative approach to assessing 
upper limb function in MS also reinforces our understand-
ing of the nature of specific movement disorders in that loss 
of rhythm generation and prolonged dwell times are seen 
in cerebellar dysfunction and are relatively preserved in 
pyramidal dysfunction.
An important limitation in using the BRAIN test to assess 
disability in MS, and other diseases that affect pyramidal or 
cerebellar function, is that it exclusively assesses upper limb 
function. EDSS scores are derived from the assessment of a 
combination of functional systems, disability in which may 
not affect upper limb function, and therefore, might not be 
detected by the BRAIN test. EDSS scores are also strongly 
influenced by ambulation. This limitation is highlighted in 
Fig. 1 that illustrates that patients with spastic paraparesis 
without upper limb pyramidal involvement have relatively 
preserved KS. Despite the inclusion of such patients in our 
study, KS remains highly correlated to pyramidal and EDSS 
scores. An additional limitation of this study is that we did 
not prospectively assess changes in BRAIN test scores with 
EDSS over time. The ability of the BRAIN test to detect 
changes in EDSS in a given patient over time needs to be 
addressed in a larger longitudinal study or clinical trial if this 
test can be used to monitor response to treatments.
In conclusion, this study has validated the BRAIN test as 
an online clinical tool that can remotely assess disability in 
MS and therefore demonstrates huge potential for monitor-
ing disease progression in clinical trials. Our further under-
standing of KS, AT and IS will guide our interpretation 
BRAIN test scores in patients with parkinsonism, pyramidal 
and cerebellar dysfunction in the future and raises the pos-
sibility of an application for this test as an outcome measure 
in a broad spectrum of neurological diseases.
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